This study demonstrated another concept alluded to above, that tumours can influence CAF activation and as a result also CAF heterogeneity; PDAC tumour-derived IL-1 steered CAFs towards an iCAF phenotype, while TGF-β biased towards myCAFs. The gene discussed is TGFB1; the disease is neoplasm.